🔗 Share this article Users Coming Off Weight-Loss Jabs Gain Back Pounds Four Times Faster Than People Using Diet and Exercise Obesity treatment often requires long-term strategies. Fresh analysis reveals that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise programs. Published data in a leading medical journal points out that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation. "Users buying these medications must be aware of the danger of rapid rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb. That rate of regain means a return to starting mass within about a year and a half. Comparing Therapies The research, which examined dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with conventional dieting. Researchers note that individuals who lose weight through lifestyle changes alone typically experience a more gradual creep back—approximately 100 grams monthly—post-intervention. Explaining the Fast Regain Doctors believe the mechanism of the jabs is key to understanding the amplified weight return. The injections mimic a body's own chemical called glucagon-like peptide-1, which controls hunger. "Artificially providing the hormone concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher. "Withdrawal of this medication means appetite is unsuppressed, making excessive eating far more likely." An Ongoing Condition? Medical guidelines recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications. A number of clinicians argue that, considering the likelihood of relapse, the treatment might need to be ongoing. This view is reinforced by pharmaceutical companies, who note that the results "underscore the persistent nature of excess weight," comparing it to managing diseases like diabetes. User Experiences People who have discontinued the jabs explain a sudden resurgence of cravings. "I experienced a trigger that goes on and I was suddenly starving," described an individual. This difficulty is exacerbated if users have not developed lasting lifestyle or habit changes during treatment. Widespread Use Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with desire continuing to grow. Use is higher among females compared to males. The middle-aged age group shows the greatest level of interest. Many access the medications through private healthcare rather than the NHS. In conclusion, experts emphasize that while these medications are potent agents for shedding pounds, they are not a magic cure and lasting health benefits relies on ongoing lifestyle changes.
Obesity treatment often requires long-term strategies. Fresh analysis reveals that patients who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise programs. Published data in a leading medical journal points out that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation. "Users buying these medications must be aware of the danger of rapid rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb. That rate of regain means a return to starting mass within about a year and a half. Comparing Therapies The research, which examined dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with conventional dieting. Researchers note that individuals who lose weight through lifestyle changes alone typically experience a more gradual creep back—approximately 100 grams monthly—post-intervention. Explaining the Fast Regain Doctors believe the mechanism of the jabs is key to understanding the amplified weight return. The injections mimic a body's own chemical called glucagon-like peptide-1, which controls hunger. "Artificially providing the hormone concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher. "Withdrawal of this medication means appetite is unsuppressed, making excessive eating far more likely." An Ongoing Condition? Medical guidelines recommend the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications. A number of clinicians argue that, considering the likelihood of relapse, the treatment might need to be ongoing. This view is reinforced by pharmaceutical companies, who note that the results "underscore the persistent nature of excess weight," comparing it to managing diseases like diabetes. User Experiences People who have discontinued the jabs explain a sudden resurgence of cravings. "I experienced a trigger that goes on and I was suddenly starving," described an individual. This difficulty is exacerbated if users have not developed lasting lifestyle or habit changes during treatment. Widespread Use Survey data show that millions of people in the UK have tried weight-loss jabs in the past year, with desire continuing to grow. Use is higher among females compared to males. The middle-aged age group shows the greatest level of interest. Many access the medications through private healthcare rather than the NHS. In conclusion, experts emphasize that while these medications are potent agents for shedding pounds, they are not a magic cure and lasting health benefits relies on ongoing lifestyle changes.